Class: Anticholinergic / Antiparkinsonian agent.
Mechanism: Selectively blocks muscarinic acetylcholine receptors in the CNS.
Improves balance between dopamine and acetylcholine in the basal ganglia → reduces tremors, rigidity, muscle stiffness, and abnormal movements.
Also has spasmolytic, antisialagogue, weak mydriatic, and cardiovagal blocking actions.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Parkinson’s disease (idiopathic, postencephalitic, arteriosclerotic).
Drug-induced movement disorders (extrapyramidal symptoms, dystonia, restlessness, involuntary movements).
ওয়েবসাইট থেকে অর্ডার করার সহজ ভিডিও গাইড।
অ্যাপ থেকে অর্ডারের সহজ ভিডিও গাইড
অ্যাপ ডাউনলোডDownload ePharma App বিস্তারিত গাইড ›Detailed App Ordering GuideAdults (Parkinsonism): Start with 1 mg daily, increase gradually (every 3–5 days) by 2 mg until 6–10 mg/day in 3–4 divided doses. Maintenance: 5–15 mg/day.
Drug-induced extrapyramidal symptoms: 5–15 mg/day in divided doses.
Elderly: May require lower doses due to higher sensitivity.
Children: Safety and efficacy not established.
Administration advice:
Take at the same time each day.
Preferably on an empty stomach; however, if nausea/dry mouth occurs, timing can be adjusted (before meals if dry mouth, after meals if drooling/nausea).
Swallow whole; do not crush or chew.
Do not stop abruptly → may worsen Parkinsonism or trigger Neuroleptic Malignant Syndrome (NMS).
Common (>10%)
Dry mouth, constipation, blurred vision, dizziness, drowsiness, upset stomach, nausea, vomiting, difficulty urinating, nervousness, headache.
Uncommon / Rare
Hallucinations, confusion, memory impairment, rash, paralytic ileus, suppurative parotitis.
Exacerbation of glaucoma (risk of blindness).
Neuroleptic Malignant Syndrome may be withdrawn suddenly.
Hypersensitivity to trihexyphenidyl.
Closed-angle glaucoma.
Thyrotoxicosis, sick sinus syndrome, severe cardiac failure with tachycardia.
Chronic pulmonary disease.
Additive anticholinergic effects: With phenothiazines, clozapine, antihistamines, TCAs, amantadine.
With MAOIs: May cause severe dryness, blurred vision, urinary retention.
With levodopa: Reduced absorption and increased involuntary movements → dose adjustment may be required.
With parasympathomimetics: Antagonizes their effect.
With metoclopramide/domperidone: May reduce their GI effects.
Additive CNS depression with alcohol, opioids, barbiturates.
Safety is not fully established. Use only if the benefits outweigh the risks.
May suppress lactation → caution during breastfeeding.
Store below 30°C, in a dry place, protected from light.
Keep out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.